Inozyme Pharma, Inc.

NASDAQ:INZY

0.9997 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 00001.9760000000000000000000
Kosten van de omzet 00.1950.1880.1820.3060.3330.3310.32400.2990.2850.2810.2810.1670.1670.15800000000
Brutowinst 0-0.195-0.188-0.1821.67-0.333-0.331-0.3240-0.299-0.285-0.281-0.281-0.167-0.167-0.15800000000
Brutowinstmarge 00000.8450000000000000000000
Onderzoek- en ontwikkelingskosten 22.47319.8921.5719.11117.80713.34111.66611.85713.83712.19110.00711.81413.5519.3468.226.6037.03625.1747.8776.4065.2793.3173.4894.134
Algemene en administratieve kosten 4.6984.9615.9075.2344.8254.7334.7286.5125.6964.7215.3845.0255.2064.9164.4354.3694.2353.1421.6711.51.4891.0031.0641.03
Verkoop- en marketingkosten 0000-0.130000000000000000000
Verkoop-, algemene en administratieve kosten 4.6984.9615.9075.2344.6954.7334.7286.5125.6964.7215.3845.0255.2064.9164.4354.3694.2353.1421.6711.51.4891.0031.0641.03
Overige kosten 00-0.003-0.0510.0140.02-0.028-0.0340-0.197-0.191-0.105-0.04-0.0650.057-0.1410.0890.1570.004-0.0030.01-0.003-0.014-0.017
Bedrijfskosten 27.17124.85127.47724.34522.50218.07416.39418.36919.53316.91215.39116.83918.75714.26212.65510.97211.27128.3169.5487.9066.7684.324.5535.164
Bedrijfsresultaat -27.171-24.851-27.665-24.345-22.808-18.074-16.394-18.369-19.533-16.912-15.391-16.839-18.757-14.262-12.655-10.972-11.271-28.316-9.548-7.906-6.768-4.32-4.553-5.164
Bedrijfsresultaat ratio 0000-11.5430000000000000000000
Totaal overige inkomsten en kosten netto 0.0970.2810.6320.9981.2641.4360.8110.9650.9890.540.13-0.0450.003-0.0180.115-0.0780.1530.2210.0750.1680.2240.2850.380.193
Inkomen voor belasting -27.074-24.57-27.033-23.347-21.544-16.638-15.583-17.404-18.544-16.372-15.261-16.884-18.754-14.28-12.54-11.05-11.118-28.095-9.473-7.738-6.544-4.035-4.173-4.971
Inkomen voor belasting ratio 0000-10.9030000000000000000000
Belastingkosten 000-0.1822.219-0.208-0.839-1.1720-0.54-0.3210.045-0.003-0.047-0.058-0.063-0.064-0.064-0.071-0.171-0.214-0.288-0.394-0.21
Nettowinst -27.074-24.57-27.033-23.347-21.544-16.638-15.583-16.232-18.544-15.832-14.94-16.929-18.754-14.28-12.54-11.05-11.118-28.095-9.473-7.738-6.544-4.035-4.173-4.971
Nettowinstmarge 0000-10.9030000000000000000000
WPA (Winst Per Aandeel) -0.43-0.39-0.44-0.38-0.35-0.29-0.35-0.370-0.36-0.38-0.71-0.79-0.6-0.53-0.47-0.61-1.55-0.47-0.51-0.43-0.27-0.28-0.33
Verwaterde WPA -0.43-0.39-0.44-0.38-0.35-0.29-0.35-0.370-0.36-0.38-0.71-0.79-0.6-0.53-0.47-0.61-1.55-0.47-0.51-0.43-0.27-0.28-0.33
EBITDA -25.475-22.959-25.45-21.84-17.905-16.305-15.252-16.762-19.335-16.723-15.212-16.661-18.575-14.095-12.488-10.814-11.148-28.273-9.522-7.881-6.743-4.3-4.534-5.145
EBITDA ratio 0000-11.3880000000000000000000